Clinical trial transparency, accessibility and availability represents a trend TrialSite News was formed to promote and contribute towards, and recently a prestigious research center in the Pacific Northwest, Fred Hutch, will seek to contribute in powerful ways to...
Fred Hutchinson Cancer Center
Category
Fred Hutchinson & UW Medicine with UCSD to Investigate Impact of COVID-19 on Those Living with HIV
Traditionally, those living with HIV are more vulnerable to infections. Do patients with HIV face greater risks with the COVID-19 pandemic? Little is known as to whether HIV puts people at higher risk in face of the SARS-CoV-2-driven COVID-19 pandemic. Researchers...
Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments
In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy...
HIV Vaccine Trials Network ‘Uhambo’ Trial Halted as The Drug Doesn’t’ Produce Results
A promising HIV clinical trial led by HIV Vaccine Trials Network (led by Fred Hutchinson Cancer Research Center) has been halted in South Africa two years prior to its scheduled completion. With high hopes, the disappointment has global HIV researchers regrouping as...
Fred Hutch’s New President Kicks off 2020: Focus Includes First & Foremost Finding Cures
Dr. Thomas J. Lynch Jr. took the top job at global cancer research leader Fred Hutchinson Cancer Research Center as president and director. A well-known cancer leader with expertise in solid tumor research, precision medicine and immune-oncology, Lynch kicks things...
Fred Hutch Shows how CRISPR Hides Healthy Cells from Leukemia Drug
Fred Hutchinson Cancer Research Center preclinical researchers seek to marry CRISPR and immunotherapy to try and improve treatment for leukemia. Why? For years, doctors have been plagued by a lose-lose trade-off: a bull’s-eye for certain cancer-killing drugs also...
Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial
Fred Hutchinson Cancer Research Center is an amazing place. At the forefront of combating cancer, recently they recently served as a clinical investigational site for a clinical trial for an investigational CAR-T cell treatment targeting multiple myeloma. The Patient...
Fred Hutchinson Cancer Research Center Collaborates with Alkermes plc to Conduct Clinical Trial for Novel Immuno-Oncology Drug Candidate
Fred Hutchinson Cancer Research Center (Fred Hutch) and Alkermes plc (ALKS) inked a collaborative deal where the parties will conduct a Phase II multi-site trial for ALKS 4230, a novel engineered fusion protein designed to selectively expand tumor-killing immune cells...
Metastatic Breast Cancer Conference Brings Hope and Help to Hundreds in Seattle, WA
Clinical trials took top billing at the fourth annual Northwest Metastatic Breast Cancer Conference held September 7th at the Amazon Meeting Center in Seattle. Scientists from Fred Hutchinson Cancer Research Center shared new treatments; National Cancer Institute...
Fred Hutch & UW Receive $12M from NIH to Investigate Rare Aggressive Skin Cancer
Jake Siegel of Fred Hutch News Service reports that a multidisciplinary research team involving University of Washington and Fred Hutchinson Cancer Research Center received a $12 million grant to study a deadly form of skin cancer known as Merkel cell carcinoma (MCC)....
Fred Hutchinson Cancer Center Researcher Awarded SITC Highest Honor
A Fred Hutchinson Cancer Research Center researcher was honored at the annual 2018 Society for Immunotherapy of Cancer (SITC) in Washington DC for work on immune-based treatments for leukemia, ovarian cancer and skin cancer, reports Susan Keown from Fred Hutch News...